Phase 4Not yet recruiting

Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia

A Randomized Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia

Sponsor
Oregon Health and Science University (Academic or other)
Enrollment
50 planned
Conditions
Hypertension; Preeclampsia
Interventions
Norethindrone 0.35 MG; Drospirenone
Ages
adults, older adults
Registry
NCT07293728

Full record on ClinicalTrials.gov

From the registry

This is an open-label, randomized feasibility trial in which participants admitted to Oregon Health \& Science University (OHSU) after a pregnancy complicated by preeclampsia who are considering a progestin-only pill contraception postpartum will be randomized to norethindrone or drospirenone for 6 weeks following hospital discharge.

Primary outcomes

  • Blood Pressure

History

  1. Primary completion expected

  2. Expected to start

  3. Last registry update

  4. Registered